Total Payments
$952,619
2024 Payments
$459,273
Companies
44
Transactions
352
Medicare Patients
2,550
Medicare Billing
$267,908
Payment Breakdown by Category
Other$946,768 (99.4%)
Food & Beverage$5,629 (0.6%)
Education$221.54 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Acquisitions | $495,133 | 2 | 52.0% |
| Current or prospective ownership or investment interest | $451,635 | 3 | 47.4% |
| Food and Beverage | $5,629 | 328 | 0.6% |
| Education | $221.54 | 6 | 0.0% |
| Unspecified | $0 | 13 | 0.0% |
Payments by Type
General
$952,619
339 transactions
Ownership
$0
13 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Anika Therapeutics, Inc. | $488,255 | 4 | $0 (2021) |
| Zimmer Biomet Holdings, Inc. | $458,513 | 1 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,733 | 103 | $0 (2024) |
| GlaxoSmithKline, LLC. | $978.01 | 62 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $362.25 | 18 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $359.24 | 14 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $328.09 | 15 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $300.52 | 35 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $143.73 | 7 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $142.55 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $459,273 | 35 | Zimmer Biomet Holdings, Inc. ($458,513) |
| 2023 | $664.81 | 33 | AstraZeneca Pharmaceuticals LP ($223.49) |
| 2022 | $785.32 | 41 | AstraZeneca Pharmaceuticals LP ($280.10) |
| 2021 | $37,583 | 51 | Anika Therapeutics, Inc. ($36,620) |
| 2020 | $452,046 | 31 | Anika Therapeutics, Inc. ($451,635) |
| 2019 | $775.29 | 45 | AstraZeneca Pharmaceuticals LP ($208.72) |
| 2018 | $751.65 | 61 | GlaxoSmithKline, LLC. ($262.88) |
| 2017 | $739.97 | 55 | GlaxoSmithKline, LLC. ($208.22) |
All Payment Transactions
352 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/13/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Airway Clearance Device | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), BREZTRI | Education | In-kind items and services | $22.52 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Cardiology | ||||||
| 10/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Education | In-kind items and services | $89.99 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $5.83 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.39 | General |
| Category: Respiratory | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/31/2024 | Zimmer Biomet Holdings, Inc. | — | Acquisitions | Cash or cash equivalent | $458,513.14 | General |
| 08/14/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.79 | General |
| Category: Respiratory | ||||||
| 07/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: RESPIRATORY | ||||||
| 07/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Respiratory | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Respiratory | ||||||
| 07/03/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: Respiratory | ||||||
| 06/12/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $24.64 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological), AIRSUPRA | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Respiratory | ||||||
| 04/25/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Respiratory | ||||||
| 04/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: RESPIRATORY | ||||||
| 04/03/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.30 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 561 | 1,027 | $205,735 | $55,637 |
| 2022 | 10 | 495 | 1,150 | $225,724 | $63,531 |
| 2021 | 13 | 651 | 1,238 | $242,916 | $68,807 |
| 2020 | 16 | 843 | 1,394 | $256,210 | $79,933 |
Total Patients
2,550
Total Services
4,809
Medicare Billing
$267,908
Procedure Codes
50
All Medicare Procedures & Services
50 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 85 | 477 | $85,680 | $29,874 | 34.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 85 | 123 | $33,825 | $11,199 | 33.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 52 | $7,800 | $4,726 | 60.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $6,900 | $2,903 | 42.1% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2023 | 95 | 96 | $28,800 | $2,400 | 8.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 85 | 86 | $4,730 | $1,736 | 36.7% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2023 | 55 | 58 | $13,688 | $925.11 | 6.8% |
| 93923 | Complete ultrasound study of arm and leg arteries | Facility | 2023 | 51 | 51 | $9,180 | $838.80 | 9.1% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2023 | 27 | 27 | $12,150 | $786.51 | 6.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 19 | 19 | $1,767 | $147.25 | 8.3% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 15 | 15 | $1,215 | $100.80 | 8.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 103 | 646 | $112,330 | $37,152 | 33.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 131 | $36,025 | $11,416 | 31.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 36 | 94 | $15,297 | $7,469 | 48.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,450 | $1,835 | 41.2% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Facility | 2022 | 58 | 61 | $18,300 | $1,581 | 8.6% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 77 | 77 | $4,235 | $1,548 | 36.6% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Facility | 2022 | 40 | 40 | $18,000 | $1,211 | 6.7% |
| 93971 | Ultrasound study of one arm or leg veins with compression and maneuvers | Facility | 2022 | 49 | 52 | $12,272 | $870.04 | 7.1% |
| 93923 | Complete ultrasound study of arm and leg arteries | Facility | 2022 | 19 | 19 | $3,420 | $328.81 | 9.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 14 | 15 | $1,395 | $119.90 | 8.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 103 | 587 | $97,786 | $34,351 | 35.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 168 | $46,200 | $15,796 | 34.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 65 | $10,334 | $5,379 | 52.1% |
| 93970 | Ultrasound scan of veins of both arms or legs including assessment of compression and functional maneuvers | Facility | 2021 | 87 | 91 | $27,300 | $2,465 | 9.0% |
About Dr. William Beliveau, MD
Dr. William Beliveau, MD is a Internal Medicine healthcare provider based in Johnson, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578588067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Beliveau, MD has received a total of $952,619 in payments from pharmaceutical and medical device companies, with $459,273 received in 2024. These payments were reported across 352 transactions from 44 companies. The most common payment nature is "Acquisitions" ($495,133).
As a Medicare-enrolled provider, Beliveau has provided services to 2,550 Medicare beneficiaries, totaling 4,809 services with total Medicare billing of $267,908. Data is available for 4 years (2020–2023), covering 50 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Critical Care Medicine, Pulmonary Disease
- Location Johnson, RI
- Active Since 07/13/2006
- Last Updated 06/26/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1578588067
Products in Payments
- SYMBICORT (Drug) $672.51
- TRELEGY ELLIPTA (Drug) $459.03
- ACTHAR (Biological) $420.54
- ZENPEP (Drug) $328.09
- TEZSPIRE (Biological) $285.65
- BREZTRI (Drug) $225.23
- FASENRA (Biological) $223.16
- STIOLTO RESPIMAT (Drug) $217.43
- ANORO (Drug) $172.70
- BREO (Drug) $154.78
- XARELTO (Drug) $142.55
- NUCALA (Biological) $136.46
- AIRSUPRA (Drug) $123.87
- LOKELMA (Drug) $105.63
- SPIRIVA RESPIMAT (Drug) $95.52
- Arikayce (Drug) $95.32
- ENTRESTO (Drug) $93.38
- LONHALA MAGNAIR (Drug) $88.60
- AirSense (Device) $86.01
- Yupelri (Drug) $82.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.